Familial glucocorticoid resistance caused by a novel frameshift glucocorticoid receptor mutation

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 12, 2010, Pages

  Trebble, P ^a   Matthews, L ^a   Blaikley, J ^a   Wayte, A W O ^b   Black, G C M ^a   Wilton, A ^b   Ray, David W ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b YSBYTY GWYNEDD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID RECEPTOR;

ADULT; APPARENT MINERALOCORTICOID EXCESS SYNDROME; ARTICLE; CASE REPORT; CELLULAR DISTRIBUTION; DIMERIZATION; ENDOCRINE DISEASE; EXON; FAMILIAL DISEASE; FEMALE; FRAMESHIFT MUTATION; GENE CONTROL; GENE EXPRESSION; GLUCOCORTICOID RESISTANCE; HUMAN; HUMAN CELL; HYDROCORTISONE BLOOD LEVEL; HYPERANDROGENISM; LIGAND BINDING; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; REPORTER GENE;

EID: 78650061727     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0705     Document Type: Article

References (38)

1. van Rossum EF, Lamberts SW 2006 Glucocorticoid resistance syndrome: a diagnostic and therapeutic approach. Best Pract Res Clin Endocrinol Metab 20:611-626 (Pubitemid 44856488)
2. Karl M, Lamberts SW, Detera-Wadleigh SD, Encio IJ, Stratakis CA, Hurley DM, Accili D, Chrousos GP 1993 Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene. J Clin Endocrinol Metab 76:683-689
3. Hurley DM, Accili D, Stratakis CA, Karl M, Vamvakopoulos N, Rorer E, Constantine K, Taylor SI, Chrousos GP 1991 Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest 87:680-686
4. Malchoff DM, Brufsky A, Reardon G, McDermott P, Javier EC, Bergh CH, Rowe D, Malchoff CD 1993 A mutation of the glucocorticoid receptor in primary cortisol resistance. J Clin Invest 91:1918-1925
5. Vottero A, Kino T, Combe H, Lecomte P, Chrousos GP 2002 A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators. J Clin Endocrinol Metab 87:2658-2667
6. Karl M, Lamberts SW, Koper JW, Katz DA, Huizenga NE, Kino T, Haddad BR, Hughes MR, Chrousos GP 1996 Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. Proc Assoc Am Physicians 108:296-307
7. Ruiz M, Lind U, Gåfvels M, Eggertsen G, Carlstedt-Duke J, Nilsson L, Holtmann M, Stierna P, Wikström AC, Werner S 2001 Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance. Clin Endocrinol (Oxf) 55:363-371
8. Kino T, Stauber RH, Resau JH, Pavlakis GN, Chrousos GP 2001 Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking. J Clin Endocrinol Metab 86:5600-5608
9. Mendonca BB, Leite MV, de Castro M, Kino T, Elias LL, Bachega TA, Arnhold IJ, Chrousos GP, Latronico AC 2002 Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene. J Clin Endocrinol Metab 87:1805-1809 (Pubitemid 34615272)
10. Charmandari E, Ichijo T, Jubiz W, Baid S, Zachman K, Chrousos GP, Kino T 2008 A novel point mutation in the amino terminal domain of the human glucocorticoid receptor (hGR) gene enhancing hGR-mediated gene expression. J Clin Endocrinol Metab 93:4963-4968
11. Charmandari E, Kino T, Ichijo T, Chrousos GP 2008 Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. J Clin Endocrinol Metab 93:1563-1572 (Pubitemid 351656488)
12. Charmandari E, Kino T, Ichijo T, Jubiz W, Mejia L, Zachman K, Chrousos GP 2007 A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance. J Clin Endocrinol Metab 92: 3986-3990
13. Charmandari E, Kino T, Ichijo T, Zachman K, Alatsatianos A, Chrousos GP 2006 Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRαR477H and hGRαG679S associated with generalized glucocorticoid resistance. J Clin Endocrinol Metab 91:1535-1543
14. Charmandari E, Raji A, Kino T, Ichijo T, Tiulpakov A, Zachman K, Chrousos GP 2005 A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity. J Clin Endocrinol Metab 90:3696-3705
15. McMahon SK, Pretorius CJ, Ungerer JP, Salmon NJ, Conwell LS, Pearen MA, Batch JA 2010 Neonatal complete generalized glucocorticoid resistance and growth hormone deficiency caused by a novel homozygous mutation in helix 12 of the ligand binding domain of the glucocorticoid receptor gene (NR3C1). J Clin Endocrinol Metab 95:297-302
16. Matthews L, Berry A, Tersigni M, D'Acquisto F, Ianaro A, Ray D 2009 Thiazolidinediones are partial agonists for the glucocorticoid receptor. Endocrinology 150:75-86
17. Matthews L, Berry A, Ohanian V, Ohanian J, Garside H, Ray D 2008 Caveolin mediates rapid glucocorticoid effects, and couples glucocorticoid Action to the antiproliferative program. Mol Endocrinol 22:1320-1330
18. Kayahara M, Ohanian J, Ohanian V, Berry A, Vadlamudi R, Ray DW 2008 MNAR functionally interacts with both NH2- and COOH-terminal GR domains to modulate transactivation. Am J Physiol Endocrinol Metab 295:E1047-E1055
19. Charmandari E, Kino T, Souvatzoglou E, Vottero A, Bhattacharyya N, Chrousos GP 2004 Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype. J Clin Endocrinol Metab 89:1939-1949
20. de Lange P, Segeren CM, Koper JW, Wiemer E, Sonneveld P, Brinkmann AO, White A, Brogan IJ, de Jong FH, Lamberts SW 2001 Expression in hematological malignancies of a glucocorticoid receptor splice variant thataugmentsglucocorticoid receptor-mediated effects in transfected cells. Cancer Res 61:3937-3941 (Pubitemid 32720954)
21. Silva AL, Romão L 2009 The mammalian nonsense-mediated mRNA decay pathway: to decay or not to decay! Which players make the decision? FEBS Lett 583:499-505
22. Dash S, Sano H, Rochford JJ, Semple RK, Yeo G, Hyden CS, Soos MA, Clark J, Rodin A, Langenberg C, Druet C, Fawcett KA, Tung YC, Wareham NJ, Barroso I, Lienhard GE, O'Rahilly S, Savage DB 2009 A truncation mutation in TBC1D4 in a family with acanthosis nigricans and postprandial hyperinsulinemia. Proc Natl Acad Sci USA 106:9350-9355
23. Sommer P, Le Rouzic P, Gillingham H, Berry A, Kayahara M, Huynh T, White A, Ray DW 2007 Glucocorticoid receptor overexpression exerts an antisurvival effect on human small cell lung cancer cells. Oncogene 26:7111-7121 (Pubitemid 350064190)
24. Doucas V, Shi Y, Miyamoto S, West A, Verma I, Evans RM 2000 Cytoplasmic catalytic subunit of protein kinase A mediates crossrepression by NF-κB and the glucocorticoid receptor. Proc Natl Acad Sci USA 97:11893-11898
25. Rangarajan PN, Umesono K, Evans RM 1992 Modulation of glucocorticoid receptor function by protein kinase A. Mol Endocrinol 6:1451-1457
26. Yudt MR, Jewell CM, Bienstock RJ, Cidlowski JA 2003 Molecular origins for the dominant negative function of human glucocorticoid receptor β. Mol Cell Biol 23:4319-4330 (Pubitemid 36666433)
27. Pujols L, Xaubet A, Ramírez J, Mullol J, Roca-Ferrer J, Torrego A, Cidlowski JA, Picado C 2004 Expression of glucocorticoid receptors α and β in steroid sensitive and steroid insensitive interstitial lung diseases. Thorax 59:687-693
28. Lu NZ, Cidlowski JA 2004 The origin and functions of multiple human glucocorticoid receptor isoforms. Ann NY Acad Sci 1024: 102-123
29. Lewis-Tuffin LJ, Jewell CM, Bienstock RJ, Collins JB, Cidlowski JA 2007 Human glucocorticoid receptor β binds RU-486 and is transcriptionally active. Mol Cell Biol 27:2266-2282
30. Hauk PJ, Goleva E, Strickland I, Vottero A, Chrousos GP, Kisich KO, Leung DY 2002 Increased glucocorticoid receptor β expression converts mouse hybridoma cells to a corticosteroid-insensitive phenotype. Am J Respir Cell Mol Biol 27:361-367
31. Hamid QA, Wenzel SE, Hauk PJ, Tsicopoulos A, Wallaert B, Lafitte JJ, Chrousos GP, Szefler SJ, Leung DY 1999 Increased glucocorticoid receptor β in airway cells of glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 159:1600-1604
32. Bamberger CM, Bamberger AM, de Castro M, Chrousos GP 1995 Glucocorticoid receptor β, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 95:2435-2441
33. Brogan IJ, Murray IA, Cerillo G, Needham M, White A, Davis JR 1999 Interaction of glucocorticoid receptor isoforms with transcription factors AP-1 and NF-κB: lack of effect of glucocorticoid receptor β. Mol Cell Endocrinol 157:95-104 (Pubitemid 29505131)
34. Otto C, Reichardt HM, Schütz G 1997 Absence of glucocorticoid receptor-β in mice. J Biol Chem 272:26665-26668
35. Galigniana MD, Radanyi C, Renoir JM, Housley PR, Pratt WB 2001 Evidence that the peptidylprolyl isomerase domain of the hsp90-binding immunophilin FKBP52 is involved in both dynein interaction and glucocorticoid receptor movement to the nucleus. J Biol Chem 276:14884-14889 (Pubitemid 37373367)
36. Pratt WB, Silverstein AM, Galigniana MD 1999 A model for the cytoplasmic trafficking of signalling proteins involving the hsp90-binding immunophilins and p50cdc37. Cell Signal 11:839-851
37. Pratt WB 1998 The hsp90-based chaperone system: involvement in signal transduction from a variety of hormone and growth factor receptors. Proc Soc Exp Biol Med 217:420-434 (Pubitemid 28135951)
38. Pratt WB, Toft DO 1997 Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18: 306-360